Current perspectives on the management of allergic rhinitis in selected Asia-Pacific countries: a meeting report

Hiroshi Chantaphakul, De Yun Wang, Hing Sang Chan, Hok-kung Marco Ho, Phaik Choo Khoo, Le Tran Quang Minh, Bee Wah Lee, Rommel Crisenio M Lobo, Tarit Muninnobpamasa, Sira Nanthapisal, C Gretchen Navarro-Locsin, Danilo A Poblete, Ing Ping Tang, Jenny Poh Lin Tang, Te-Huei Yeh, Dinesh Nagrale

Abstract

A virtual roundtable meeting involving 16 allergic rhinitis (AR) management specialists from Asia-Pacific countries was held in September 2021 to gather insight into real-world treatment practices in the region. The discussion centred around specialists’ responses to a previously completed self-administered, purpose-designed online questionnaire that covered several topics of interest to allergy specialists: assessment and monitoring of AR with a focus on the role of the visual analogue scale as a diagnostic and monitoring tool; preferred treatment options for AR focusing on second-generation antihistamines; and patient education requirements and methods to deliver appropriate patient-centred information. This report summarizes key points from the meeting.

Article Details

Article Type

Meeting Report

DOI

10.7573/dic.2022-5-3

Publication Dates

Accepted: ; Published: .

Citation

Chantaphakul H, Wang DY, Chan HS, Ho HM, Khoo PC, Minh LTQ, Lee BW, Lobo RCM, Muninnobpamasa T, Nanthapisal S, Navarro-Locsin CG, Poblete DA, Tang IP, Tang JPL, Yeh T-H, Nagrale D. Current perspectives on the management of allergic rhinitis in selected Asia-Pacific countries: a meeting report. Drugs Context. 2022;11:2022-5-3. https://doi.org/10.7573/dic.2022-5-3

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.